[Clinico-therapetic trials with a new surface antimycotic agent: pimaricin, associated with dexamethasone and neomycin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D013501:Surface-Active Agents / Q000627:therapeutic use*
D000935:Antifungal Agents; D013501:Surface-Active Agents; D003907:Dexamethasone; D009355:Neomycin
Esperienze clinico-terapeutiche con un nuovo antimicotico di superficie: la pimaricina, associata a desametazone e neomicina.